Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension

Journal of Human Hypertension volume 15, pages 857–862 (2001)Cite this article

Abstract

The objective of this study was to compare quality of life and incidence of dry persistent cough among patients treated with eprosartan and enalapril for mild–moderate hypertension. This was a randomised 26-week double-blind controlled trial carried out in clinics in nine countries of North America, Europe and South Africa. A total of 529 patients aged 18 and over with diastolic blood pressure between 95 mm Hg and 114 mm Hg were studied. Treatment comprised of eprosartan or enalapril monotherapy for 12 weeks with the option of hydrochlorothiazide addition for the remaining 14 weeks. The primary outcome measures were cough and the Psychological General Wellbeing Index (PGWB) total and subscales (anxiety, self-control, depression, general health, positive wellbeing and vitality). The results were that 17.8% of enalapril patients and 13.2% of eprosartan patients withdrew from randomised treatment. Those on enalapril were twice as likely to have gained a definite or possible cough by study end point as those on eprosartan (7.6% vs 3.2%) P = 0.099. At monotherapy end point the differences were greater (9.9% vs 2.1%) and of statistical significance, P = 0.001. Patients treated with enalapril, however, had small but significant improvements in measures of self-control and total PGWB compared with those on eprosartan. The effect sizes of 0.2 or less indicated that there were small differences. In conclusion eprosartan was associated with fewer coughs than enalapril but it performed less well on some aspects of quality of life.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Berkin KE, Ball SG Cough and angiotensin converting enzyme inhibition BMJ 1988 296 1279

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Inman WH et alPostmarketing surveillance of enalapril. I: results of prescription-event monitoring BMJ 1988 297 826–829

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Coulter DM, Edwards IR Cough associated with captopril and enalapril BMJ 1987 294 1521–1523

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Israili ZH, Hall WD Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy Ann Intern Med 1992 117 234–242

    Article  CAS  PubMed  Google Scholar 

  5. Simon SR, Black HR, Moser M, Berland WE Cough and ACE inhibitors Arch Intern Med 1992 152 1698–1700

    Article  CAS  PubMed  Google Scholar 

  6. Fletcher AE, Palmer AJ, Bulpitt CJ Cough with angiotensin converting enzyme inhibitors: how much of a problem? J Hypertens 1994 12 (Suppl 2): S43–S47

    Google Scholar 

  7. Gandhi SK, Kong SX Quality-of-life measures in the evaluation of antihypertensive drug therapy: reliability, validity, and quality-of-life domains Clin Ther 1996 18 1277–1295

    Article  Google Scholar 

  8. Williams GH Assessingpatient wellness: new perspectives on quality of life and compliance Am J Hypertens 1998 11 186S–191S

    Article  CAS  PubMed  Google Scholar 

  9. Applegate WB et alA randomised controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women Arch Intern Med 1991 151 1817–1823

    Article  CAS  PubMed  Google Scholar 

  10. Herrick AL et alComparison of enalapril and atenolol in mild to moderate hypertension Am J Med 1989 86 421–426

    Article  CAS  PubMed  Google Scholar 

  11. Testa MA, Anderson RB, Nackley JF, Hollenberg NK and the Quality-of-Life Hypertension Study Group Quality of life and antihypertensive therapy in men. A comparison of captopril and enalapril N Engl J Med 1993 328 907–913

    Article  CAS  PubMed  Google Scholar 

  12. Croog SH et alEffects of antihypertensive medications on quality of life in elderly hypertensive women Am J Hypertens 1994 7 329–339

    Article  CAS  PubMed  Google Scholar 

  13. Omvik P et alDouble-blind parallel comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensivepatients: a multicentre study J Hypertens 1993 11 103–113

    Article  CAS  PubMed  Google Scholar 

  14. Townsend R, Haggert B, Liss C, Edelman JM Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide inpatients with essential hypertension Clin Ther 1995 17 911–923

    Article  CAS  PubMed  Google Scholar 

  15. Ramsay LE, Yeo WW ACE inhibitors, angiotensin II antagonists and cough. The Losartan Study Group J Hum Hypertens 1995 9 (Suppl 5) S51–S54

    Google Scholar 

  16. Lacourciere Y The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group Int J Clin Pract 1999 53 99–103

    CAS  PubMed  Google Scholar 

  17. Paster RZ et alUse of losartan in the treatment of hypertensivepatients with a history of cough induced by angiotensin-converting enzyme inhibitors Clin Ther 1998 20 978–989

    Article  CAS  PubMed  Google Scholar 

  18. Benz J et alValsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide J Clin Pharmacol 1997 37 101–107

    Article  CAS  PubMed  Google Scholar 

  19. Weir MR et alEfficacy, tolerability and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS inpatients with essential hypertension Clin Ther 1996 18 411–428

    Article  CAS  PubMed  Google Scholar 

  20. Oparil S et alEfficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodopine, alone or with hydro-chlorothiazide, inpatients with essential hypertension Clin Ther 1996 18 608–625

    Article  CAS  PubMed  Google Scholar 

  21. Dahlöf Bet alfor the LOA Study groupMain results of the losartan versus amlodopine (LOA) study on drug tolerability and psychological general well-being J Hypertens 1997 15 1327–1335

    Article  PubMed  Google Scholar 

  22. McClellan KJ, Balfour JA Eprosartan Drugs 1998 55 713–718. Discussion pp 719–720

    Google Scholar 

  23. Elliott W for the Eprosartan Study Group Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensivepatients J Hum Hypertens 1999 13 413–417

    Article  Google Scholar 

  24. Argenziano L, Trimarco B Effect of eprosartan and enalapril in the treatment of elderly hypertensivepatients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group Curr Med Res 1999 15 9–14

    Article  CAS  Google Scholar 

  25. Levine B Effect of eprosartan and enalapril in the treatment of black hypertensivepatients: subgroup analysis of a 26-week double-blind multicentre study. Eprosartan Multinational Study Group Curr Med Res 1999 15 25–32

    Article  CAS  Google Scholar 

  26. Dupuy HJ The Psychological Wellbeing Index. In: Wenger NK, Mattson ME, Furberg CD, Eliason J (eds) Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies Le Jacq: New York 1984 pp 170–183

    Google Scholar 

  27. Wiklund I, Halling K, Långström G The Psychological General Wellbeing Index (PGWB), a reliable tool for use in cross-cultural multicentre clinical trials (Abstract) Qual Life Res 1995 4 503

    Google Scholar 

  28. Badia X, Gutiérrez F, Wiklund I, Alonso J Validity and reliability of the Spanish version of the Psychological General Wellbeing Index Qual Life Res 1996 5 101–108

    Article  CAS  PubMed  Google Scholar 

  29. Fletcher AE et alQuality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine Hypertension 1992 19 499–507

    Article  CAS  PubMed  Google Scholar 

  30. Kazis LE, Anderson JJ, Meenan RF Effect sizes for interpreting changes in health statistics Med Care 1989 27 (Suppl) S178–S189

    Article  Google Scholar 

  31. Bulpitt CJ, Fletcher AE Measurements of quality of life in hypertension: a practical approach Br J Clin Pharmacol 1990 30 353–364

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Crown S, Crisp AH A short diagnostic self-rating scale for psychoneuroticpatients. The Middlesex Hospital Questionnaire (MHQ) Br J Psychiatr 1966 112 917–923

    Article  CAS  Google Scholar 

  33. House JS Work Stress and Social Support Addison-Wesley: Reading Mass 1981

    Google Scholar 

  34. Bulpitt CJ, Dollery CT, Carne S A symptom questionnaire for hypertensivepatients J Chron Dis 1974 27 309–323

    Article  CAS  PubMed  Google Scholar 

  35. Tikkanen I, Omvik P, Jensen HA for the Scandinavian Study Group Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril inpatients with essential hypertension J Hypertens 1995 13 1343–1351

    Article  CAS  PubMed  Google Scholar 

  36. Mimran A et alA randomised, double-blind comparison of the angiotensin II receptor anatagonist irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension J Hum Hypertens 1998 12 203–208

    Article  CAS  PubMed  Google Scholar 

  37. Ramsay LE, Yeo WW on behalf of the Losartan Cough Study Group Double-blind comparison of losartan, lisinopril and hydrochlorothiazide in hypertensivepatients with a previous angiotensin converting enzyme inhibitor-associated cough J Hypertens 1995 13 (Suppl 1) S73–S76

    Article  Google Scholar 

  38. Reisin L, Schneeweiss A Spontaneous disappearance of cough induced by angiotensin-converting enzyme inhibitors (captopril or enalapril) Am J Cardiol 1992 70 398–399

    Article  CAS  PubMed  Google Scholar 

  39. Croog SH et alThe effects of antihypertensive therapy on the quality of life N Engl J Med 1986 314 1657–1664

    Article  CAS  PubMed  Google Scholar 

  40. Machin D, Campbell MJ Statistical Tables for the Design of Clinical Trials Blackwell Scientific Publications: Oxford 1987

    Google Scholar 

  41. Fletcher AE Measuring the effects of hypertensive therapy upon the quality of life Curr Opin Nephrol Hypertens 1995 4 538–542

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Smithkline Beecham Pharmaceuticals (since merged into GlaxoSmithkline) funded the trial. Dr Diana Elbourne of LSHTM was helpful in discussing some of the statistical issues.

Author information

Authors and Affiliations

  1. Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK

    E Breeze, MD Donoghue & AE Fletcher

  2. Institute for Cancer Research, London School of Hygiene and Tropical Medicine, London, UK

    EC Rake

Authors
  1. E Breeze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. EC Rake
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. MD Donoghue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. AE Fletcher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Breeze.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Breeze, E., Rake, E., Donoghue, M. et al. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension. J Hum Hypertens 15, 857–862 (2001). https://doi.org/10.1038/sj.jhh.1001282

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001282

Keywords

This article is cited by

Search

Advanced search

Quick links